UFF
TGTX icon

USA FINANCIAL FORMULAS’s TG Therapeutics TGTX Stock Holding History

USA FINANCIAL FORMULAS’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.8K Buy
+1,344
New +$55K 0.01% 221

Other funds holding TGTX

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

USA FINANCIAL FORMULAS's TGTX Position: Q2 2026 in Review

USA FINANCIAL FORMULAS opened a new position in TG Therapeutics (TGTX) in Q2 2026: 1,344 shares worth $73.8K. The stake represents 0.01% of the portfolio and ranks #221 among its holdings.

156 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • USA FINANCIAL FORMULAS held 1,344 shares of TG Therapeutics worth $73.8K as of Q2 2026.
  • TG Therapeutics was a new USA FINANCIAL FORMULAS position in Q2 2026.
  • TG Therapeutics made up 0.01% of USA FINANCIAL FORMULAS's portfolio in Q2 2026, its #221 holding.
  • 156 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on USA FINANCIAL FORMULAS's 13F filing for Q2 2026, filed 4 Aug 2026.